IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its first ...

Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical trialTen globally leading transplant hospitals are ...

Q1 2025 Earnings Call Transcript May 12, 2025 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.83, ...

Q1 2025 Earnings Call Transcript May 13, 2025 Capricor Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

UC researchers created a lab-on-a-chip system to track a patient’s cortisol levels. It consists of a disposable collection ...

According to WHO, India accounted for the highest share of global tuberculosis cases in 2023—26%. However, the country has a ...

The Guiding an Improved Dementia Experience (GUIDE) model could be further strengthened by enhancements and clarifications of ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

Welcome to the OraSure Technologies, Inc. 2025 first-quarter earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the ...

Welcome to the Conference Call hosted by Daré Bioscience to review the company's First Quarter 2025 Financial Results and to provide the Business Update. This call is being recorded. My name is Gayle ...

Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET. Company Participants. Stephanie Fagan - Chief Corporate Affairs Officer Rob Bar ...

What if physicians could diagnose Alzheimer's disease before major symptoms appeared?That's possible with an FDA-approved ...